文献速递角膜与眼表疾病

p16INK4a过表达作为眼表鳞状上皮肿瘤生存预测因子

p16INK4a overexpression as a predictor of survival in ocular surface squamous neoplasia.
PubMed 文献 · Br J Ophthalmol · 2018-03-06

研究评估64例眼表鳞状上皮肿瘤(OSSN)患者(早期35例、晚期29例)p16INK4a表达与甲基化状态及其与临床病理特征和生存的关联,随访36-58个月(平均48±3.6个月)。p16INK4a过表达18/64(28%),高甲基化35/64(54.7%);从早期到晚期肿瘤阶段,p16INK4a表达逐渐显著增加(0%-48%,P=0.03),甲基化逐渐显著降低(75%-16%,P=0.001)。晚期T分期中p16INK4a过表达与无病生存期缩短(P=0.02)及预后不良(HR,0.2;P=0.03)相关;结论认为晚期AJCC分期伴p16INK4a过表达的OSSN患者可能需要更积极的治疗。

要点

  • 64例OSSN中p16INK4a过表达18/64(28%),高甲基化35/64(54.7%)。
  • 早期到晚期肿瘤阶段p16INK4a表达显著增加(0%-48%,P=0.03),甲基化显著降低(75%-16%,P=0.001)。
  • 晚期T分期中p16INK4a过表达与无病生存期缩短(P=0.02)及预后不良(HR,0.2;P=0.03)相关。

核心结论

  • 晚期AJCC分期伴p16INK4a过表达的OSSN患者可能需要更积极的治疗。
  • 日光暴露导致的p16INK4a基因表观遗传失活可能是OSSN发病机制之一。

研究设计与样本

  • 研究纳入64例OSSN患者(早期35例、晚期29例,按AJCC分期),随访36-58个月(平均48±3.6个月)。
  • 采用免疫组化检测p16INK4a蛋白表达,甲基化特异性PCR检测p16INK4a基因甲基化状态。

主要发现

  • p16INK4a过表达见于18/64(28%)OSSN病例,高甲基化见于35/64(54.7%)病例。
  • 从早期到晚期肿瘤阶段,p16INK4a表达逐渐显著增加(0%-48%,P=0.03),甲基化逐渐显著降低(75%-16%,P=0.001)。
  • 在早期和晚期T分期中,p16INK4a过表达均与睑缘位置和弥漫性生长模式显著相关。
  • 在早期和晚期T分期中,p16INK4a高甲基化均与较长日光暴露史显著相关。
  • 在晚期T分期中,p16INK4a过表达与无病生存期缩短(P=0.02)及预后不良(HR,0.2;P=0.03)相关。

临床怎么用

  • 作者认为,晚期AJCC分期伴p16INK4a过表达的OSSN患者可能需要更积极的治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To evaluate the expression and methylation status of the p16INK4a gene in early and advanced American Joint Committee on Cancer (AJCC) stages of ocular surface squamous neoplasia (OSSN) and to correlate its association with clinicopathological features and survival. METHODS: Sixty-four (35 early and 29 advanced AJCC stage) patients with OSSN formed part of this study and were followed up for 36-58 (mean 48±3.6) months. Immunohistochemical expression of the p16INK4a protein and methylation status of the p16INK4a gene were determined by methylation-specific PCR. RESULTS: Overexpression of p16INK4a was observed in 18/64 (28%) and hypermethylation in 35/64 (54.7%) OSSN cases. A gradual significant increase in the expression of p16INK4a (0%-48%, P=0.03) and decrease in its methylation (75%-16%, P=0.001) was observed with disease progression from early to advanced tumour stage. Overexpression of p16INK4a was significantly associated with palpebral location and diffuse growth pattern in both early and advanced T stage. Hypermethylation of p16INK4a was significantly associated with history of longer sunlight exposure in both early and advanced T stage of OSSN cases. In advanced T stage, p16INK4a overexpression was associated with reduced disease-free survival (P=0.02) and poor prognosis (HR, 0.2; P=0.03). CONCLUSIONS: OSSN patients presenting at an advanced AJCC stage with p16INK4a overexpression may require more aggressive treatment. Epigenetic inactivation of the p16INK4a gene due to sunlight exposure could be responsible for pathogenesis of OSSN.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Chauhan S, Sen S, Sharma A, et al. p16INK4a overexpression as a predictor of survival in ocular surface squamous neoplasia. Br J Ophthalmol. 2018. PMID: 29511060. doi:10.1136/bjophthalmol-2017-311276

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。